Little is known about current characteristics of individuals with tattoos. We quantified the prevalence of tattooing and associations of demographic, health, and risk-behavior factors with tattooing. We computed adjusted prevalence ratios (PR) of tattooing in a population-based analysis of 18,687 Utah adults ages 18 years and older from the 2020–2021 Behavioral Risk Factor Surveillance System survey. The prevalence of tattooing was 26% among women and 22% among men, with the highest prevalence among those ages 25–29 years (women: 45%; men: 34%). Tattoo prevalence was higher among individuals with less than a college degree and those without religious affiliation. Tattoo prevalence was higher among indviduals with current tobacco use (women: PR = 2.89 [95% confidence interval (CI): 2.60, 3.20]; men: 3.39 [2.98, 3.86]), e-cigarette use (women: 2.44 [2.21, 2.69]; men: 2.64 [2.37, 2.94]), and heavy alcohol use (women: 2.16 [1.93, 2.43]; men: 1.89 [1.63, 2.19]). Tattoo prevalence was lower among individuals receiving a flu vaccine (women: 0.84 [0.76, 0.92]; men: 0.75 [0.67, 0.84]) or COVID-19 vaccine (women: 0.65 [0.54, 0.79]; men: 0.75 [0.61, 0.92]). Tattoo prevalence was higher among women and individuals under age 30 years. Several risk behaviors were associated with tattooing. Tattoo studios/conventions may present opportunities for partnership with tobacco cessation, alcohol reduction, and vaccination public health initiatives.
No takes yet. Share an insight, caveat, or question.
McCarty et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: